You are here: Industry Insights > Covax

News List

WHO agrees on compensation plan in case of serious side effects of COVAX vaccine expresspharma
February 23, 2021
By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process, informed WHO.
UK to pledge to share surplus Covid-19 vaccines at G7 meeting pharmaceutical-technology
February 20, 2021
UK Prime Minister Boris Johnson will pledge to donate surplus Covid-19 vaccines to poorer countries at a virtual G7 meeting.
Africa to receive first COVID-19 vaccine doses in February europeanpharmaceuticalreview
February 10, 2021
COVAX has allocated 90 million doses of AstraZeneca’s COVID-19 vaccine and 320,000 doses of the Pfizer-BioNTech vaccine to African countries.
Pakistan says China’s Sinopharm vaccine not effective for people over 60 years expresspharma
February 05, 2021
Pakistan on Thursday said that China’s Sinopharm vaccine is not effective for people over 60 years of age, a day after it began its countrywide coronavirus vaccination programme with the Chinese jabs.
Pakistan receives first batch of COVID vaccines from China expresspharma
February 02, 2021
Pakistan on Monday received the first batch of 500,000 doses of the coronavirus vaccine donated by its closest ally, China, as the country gears up to kick start its immunisation drive later this week.
Mexico to buy AstraZeneca vaccine from India: President Andres Manuel Lopez Obrador expresspharma
February 01, 2021
Mexico also has a deal with AstraZeneca to produce its vaccine for distribution in Latin America, with financial support from the foundation of Mexican billionaire Carlos Slim.
Supplied COVID-19 vaccines to nine countries, will gradually send to COVAX facility: India at UN expresspharma
January 27, 2021
We are fulfilling our commitment to make our vaccine production and delivery capacity available for the benefit of the entire humanity, said K Nagaraj Naidu, India’s Deputy Permanent Representative to the UN Ambassador.
Australia approves Pfizer-BioNTech’s Covid-19 vaccine pharmaceutical-technology
January 26, 2021
Australia’s Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer-BioNTech Covid-19 vaccine for use in people aged 16 years and above.
COVAX announces new agreement, plans for first deliveries worldpharmanews
January 25, 2021
COVAX announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has already received WHO emergency use listing.
Pfizer, BioNTech announce agreement with COVAX for advance purchase of COVID-19 vaccine expresspharma
January 25, 2021
Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 vaccine. The doses will be delivered throughout 2021.

Previous page 1 2 3 4 5 6 7 8 Next page